Imagine you have a product that made $919 million in sales last year. Now imagine having to stop supplying that product not just to one market, but all over the world. That is precisely the situation that Pfizer is in right now.
Our Analysis:
While the price is below 40.50, follow the recommendations below:
- Time frame: D1
- Recommendation: short position
- Entry point: 39.05
- Take Profit 1: 37.70
- Take Profit 2: 37.10
Alternative scenario:
If the level 40.50 is broken-out, follow the recommendations below:
- Time frame: D1
- Recommendation: long position
- Entry point: 40.50
- Take Profit 1: 41.60
- Take Profit 2: 42.20
No comments:
Post a Comment